- Cystic Fibrosis IVF Screening in Thailand: PGT-M Testing & Considerations
-
Patients or carriers of cystic fibrosis undergoing IVF in Thailand can use PGT-M technology to screen embryos for CFTR gene mutations, preventing transmission to offspring. This article provides a realistic reference on testing principles, applicable conditions, procedures, timeline, and risk warnings.
- Thai IVF Success Cases: Key Medical Factors and Decision-Making Advice
-
Thai IVF success cases are not mystical; they are determined by medical variables such as age, ovarian function, embryo chromosomal normality rate, and laboratory conditions. This knowledge base helps understand the real logic behind successful cases, suitable for reference before traveling to Thailand.
- Can IVF in Thailand succeed after chemotherapy? | Reproductive Medicine Knowledge Base
-
Ovarian function may be impaired after chemotherapy. Whether IVF in Thailand can succeed depends on the chemotherapy regimen, age, AMH level, and follicle reserve. A comprehensive assessment of hormone levels, chromosomes, and infectious disease risks is required. Some patients may need ovarian tissue freezing or egg donation. This article analyzes the conditions, procedures, and risks from a reproductive specialist's perspective.
- Thailand IVF Diet & Hygiene Guide: Precautions & Common Questions
-
During the IVF process in Thailand, diet and hygiene directly impact treatment outcomes. This article details how to maintain food safety, avoid food poisoning, supplement nutrition appropriately, and follow hospital hygiene management requirements to help patients reduce infection risks and improve embryo implantation rates.
- Can IVF in Thailand Transfer Twins? - Policy Regulations and Medical Conditions Explained
-
Thailand allows double embryo transfer but with restrictions. Doctors evaluate transfer numbers based on patient age, uterine environment, embryo quality, and other factors. Single embryo transfer is usually recommended for women under 35, while 2 embryos may be considered for those over 35 or with multiple failed transfers. Risks of multiple pregnancies, including premature birth and gestational hypertension, must be fully assessed.